Mohit Agrawal

DeepTek’s CXR AI solution is a WHO-recommended tool designed to detect Tuberculosis ( age 4+) and 21 other critical lung conditions with speed and precision—enabling early intervention, reducing disease burden, and improving outcomes at scale. A key differentiator is its ability to interpret pediatric chest X-rays, including the detection of pediatric TB and pneumonia—addressing a crucial diagnostic gap in younger populations often underserved by conventional AI models. DeepTek’s CXR AI solution has already screened over 2 million individuals across 325+ sites in 8+ countries. Cleared by the US FDA and CE marked in recognized regions, the solution is approved for use in both adult and pediatric populations aged 4 years and above. By accelerating diagnosis, improving radiologist productivity, and supporting high-quality care delivery, this AI-powered platform is helping healthcare systems make lung health screening more accessible, scalable, and impactful—particularly in the global fight against TB.